Comparison of the Prognostic Utility of the Revised International Prognostic Scoring System and the French Prognostic Scoring System in Azacitidine-Treated Patients with Myelodysplastic Syndromes

The revised International Prognostic Scoring System (IPSS-R) was developed in a cohort of untreated myelodysplastic syndromes (MDS) patients. A French Prognostic Scoring System (FPSS) was recently reported to identify differential survival among azacitidine-treated patients with high-risk MDS. We ap...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Br J Haematol
Päätekijät: Zeidan, Amer M, Lee, Ju-Whei, Prebet, Thomas, Greenberg, Peter, Sun, Zhuoxin, Juckett, Mark, Smith, Mitchell R, Paietta, Elisabeth, Gabrilove, Janice, Erba, Harry P, Tallman, Martin S., Gore, Steven D.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4299460/
https://ncbi.nlm.nih.gov/pubmed/24712482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.12884
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia